The Abscopal Response
An ‘abscopal response’ refers to radiation being delivered to a single tumour resulting in eradication or shrinking of distant, non-irradiated tumours. While it can produce an extraordinarily potent anti-cancer response, it is extremely rare.
Recent research points to an abscopal response being an immune-based phenomenon, involving the generation of CD8+ T cells and Type 1 interferons.
In clinical trials with Veyonda®, an abscopal response has been seen in a number of cases in association with locally-delivered external beam radiotherapy in patients with late-stage cancer. For more detail refer to the Noxopharm White Papers.
Veyonda® is currently not approved in Australia or any other country